Fovinaciclibum
Fovinaciclib is an orally active CDK (CDK4/6) inhibitor with antitumor activity.
For research use only. We do not sell to patients.
- CAS No.: 2146171-49-3
- Formula: C29H40N8OS
- Molecular Weight:548.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vitro
CDKs are a class of cyclin-dependent serine/threonine kinases that are activated upon binding to cyclins, precisely driving transitions and regulating progression through the various stages of the cell cycle.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2146171-49-3
-
Molecular Weight 548.75
-
Formula C29H40N8OS
-
SMILES
O=C(N(C)C)C1=C(C2CCCC2)C3=C(C=NC(NC4=NC=C(N5CCC(CC5)N6CCN(CC6)C)C=C4)=N3)S1
-
Synonyms
Fovinaciclib
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Fovinaciclibum Related Classifications
HY-159535 Related Classifications
Powered by Bioz